{"protocolSection": {"identificationModule": {"nctId": "NCT04145635", "orgStudyIdInfo": {"id": "PVP017"}, "organization": {"fullName": "Procyrion", "class": "INDUSTRY"}, "briefTitle": "The Aortix CRS Pilot Study", "officialTitle": "An Evaluation of the Safety and Performance of the Aortix System for Intra-Aortic Mechanical Circulatory Support in Patients With Cardiorenal Syndrome"}, "statusModule": {"statusVerifiedDate": "2024-04", "overallStatus": "COMPLETED", "startDateStruct": {"date": "2021-02-05", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2022-10-07", "type": "ACTUAL"}, "completionDateStruct": {"date": "2023-03-09", "type": "ACTUAL"}, "studyFirstSubmitDate": "2019-10-25", "studyFirstSubmitQcDate": "2019-10-28", "studyFirstPostDateStruct": {"date": "2019-10-30", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2023-10-20", "resultsFirstSubmitQcDate": "2024-04-08", "resultsFirstPostDateStruct": {"date": "2024-04-17", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2024-04-08", "lastUpdatePostDateStruct": {"date": "2024-04-17", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Procyrion", "class": "INDUSTRY"}, "collaborators": [{"name": "Procyrion Australia Pty Ltd", "class": "UNKNOWN"}]}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true, "isUnapprovedDevice": true, "isUsExport": true}, "descriptionModule": {"briefSummary": "The Aortix CRS Pilot Study: An Evaluation of the Safety and Performance of the Aortix System for Intra-Aortic Mechanical Circulatory Support in Patients with Cardiorenal Syndrome", "detailedDescription": "The study is a prospective, multi-center, non-randomized feasibility study to evaluate the safety and performance of the Aortix System in patients hospitalized with acute decompensated heart failure (ADHF) and worsening renal function refractory to medical management with persistent congestion. The Aortix system consists of the Aortix Delivery System, Introducer Set, the Aortix Pump, the Aortix Control System, and the Aortix Retrieval System."}, "conditionsModule": {"conditions": ["Heart Failure; With Decompensation", "Cardiorenal Syndrome", "Cardio-Renal Syndrome", "Heart Failure", "Heart Failure\uff0cCongestive", "Heart Failure, Systolic", "Heart Failure, Diastolic"], "keywords": ["mechanical circulatory support, percutaneous"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 21, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Aortix Device", "type": "EXPERIMENTAL", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System", "interventionNames": ["Device: Aortix System"]}], "interventions": [{"type": "DEVICE", "name": "Aortix System", "description": "Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function.", "armGroupLabels": ["Aortix Device"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Serious Adverse Events", "description": "Rate of Occurrence of Serious Adverse Events (rate will be calculated and reported)", "timeFrame": "30 days"}, {"measure": "Serious Procedure Related Adverse Events", "description": "Rate of Occurrence of Serious Procedure Related Adverse Events (rate will be calculated and reported)", "timeFrame": "30 days"}, {"measure": "Device Performance", "description": "Deployment and retrieval procedures success rates (rates will be calculated and reported).", "timeFrame": "7 days"}, {"measure": "Device Performance", "description": "Rate of occurrence of ADS, ARS and pump device-related adverse events (includes device malfunctions) (rate will be calculated and reported)", "timeFrame": "30 days"}, {"measure": "Effectiveness", "description": "Clinically significant decongestion as measured by the PA catheter. % of patients with a decrease in either CVP or PCWP of \\> 20%.", "timeFrame": "7 days"}, {"measure": "Urine Output", "description": "Change in Urine Output Assessed as the hourly rate of urine output before pump placed vs hourly rate of urine output over the Aortix therapy period (until congestion target met or therapy deemed ineffective)", "timeFrame": "7 day period starting from implant"}, {"measure": "NT-pro-BNP (Brain Natriuretic Peptide)", "description": "Change in NT-pro-BNP (pre-implant vs when congestion target is met or therapy deemed ineffective)", "timeFrame": "7 days"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1) Admitted to the hospital with a primary diagnosis of acute decompensated heart failure, either heart failure with reduced or preserved ejection fraction (HFrEF, HFpEF or HFmEF);\n\n2) Worsening renal function (serum creatinine increase by \u22650.3 mg/dl \\[\u226527 \u03bcmol/L\\]) despite 48 hours of intravenous diuretic therapy Increase can be compared to a baseline value taken within 90 days of hospitalization or during hospitalization;\n\n3) Objective measure of congestion (Elevated PCWP \\[\u226520 mmHg\\] OR Elevated CVP \\[\u226512 mmHg\\]) obtained via catheter measurement;\n\n4) Persistent clinical signs and/or symptoms of congestion despite diuretic therapy (one or more of the following):\n\n1. dyspnea at rest or with minimal exertion,\n2. paroxysmal nocturnal dyspnea,\n3. orthopnea,\n4. lower extremity edema (\u22652+),\n5. elevated jugular venous pressure,\n6. pulmonary rales,\n7. enlarged liver or ascites,\n8. pulmonary vascular congestion on chest x-ray;\n\n   5) Age \\>21 years.\n\n   -\n\n   Exclusion Criteria:\n\n   1) Treatment with high dose IV inotropes within the last 48 hours. High dose is defined as \\> 1 unit of inotrope (excluding digoxin) as follows: 5 \u00b5g/kg/min dopamine = 1 unit, 5 \u00b5g/kg/min dobutamine= 1 unit, 0.375 \u00b5g/kg/min milrinone = 1 unit, (for example, dopamine 2.5 \u00b5g/kg/min + dobutamine 2.5 \u00b5g/kg/min = 1 unit; dobutamine 2.5 \u00b5g/kg/min + milrinone 0.1875 \u00b5g/kg/min = 1 unit);\n\n   2) Treatment with vasopressors to maintain blood pressure as per exclusion number 3;\n\n   3) Active and ongoing hypotension defined as a systolic blood pressure \\< 90 mmHg lasting more than 30 minutes or a mean arterial pressure (MAP) \\< 60 mmHg lasting more than 30 minutes;\n\n   4) Acute Kidney Failure defined as increase in serum creatinine to \u22654.0 mg/dL (\u2265353.6 \u03bcmol/L) within the last 48 hours;\n\n   5) Exposure to intravenous contrast, aminoglycosides or high dose NSAIDS in the 48 hours before enrollment;\n\n   6) Known or suspected contrast induced nephropathy;\n\n   7) Prior kidney transplant, isolated single kidney, stage V Chronic Kidney Disease (eGFR \u226415) at admission OR use of dialysis, continuous renal replacement therapy (CRRT) or aquapheresis (ultrafiltration) in last 90 days;\n\n   8) Urologic intervention (except indwelling urinary (Foley) catheter)) within the last 7 days;\n\n   9) Known cirrhosis or shock liver;\n\n   10) Presence of an active infection;\n\n   11) Prior heart transplant in the last 2 years, heart failure due to rejection of a previous heart transplant, planned heart transplantation before the 30-day follow-up visit;\n\n   12) Current or previous support with a durable LVAD at any time or use of an intra-aortic balloon pump, extracorporeal membrane oxygenation (ECMO), or percutaneous ventricular assist devices (e.g. Impella or TandemHeart) currently or within the last 30 days;\n\n   13) Patient has known hypo- or hyper coaguable state such as disseminated intravascular coagulation or heparin induced thrombocytopenia (HIT);\n\n   14) Known cardiac amyloidosis;\n\n   15) Acute myocardial infarction Type 1 within 30 days of enrollment, or planned coronary revascularization;\n\n   16) Stroke within 30 days of enrollment;\n\n   17) Severe Bleeding Risk (any of the following):\n\na) Previous intracranial bleed unless there is documentation in the medical record (from a physician that is not part of the study) that the patient can safely use anticoagulation for 7 days, b) GI bleeding within 6 months requiring hospitalization and/or transfusion, c) Recent major surgery within 6 months if the surgical wound is judged to be associated with an increased risk of bleeding, d) Endovascular procedure with ilio-femoral access \\> 6 FR within 30 days, e) Platelet count \\<75,000 cells/mm3, f) Uncorrectable bleeding diathesis or coagulopathy (e.g. INR \u22652 not due to anticoagulation therapy);\n\n18) Current endovascular stent graft in the descending aorta or any femoro-iliac vessels;\n\n19) Contraindicated Anatomy:\n\n1. Descending aortic anatomy that would prevent safe placement of the device \\[\\<18mm or \\>31mm aorta diameter at deployment location (measured between the superior aspect of the T10 vertebra and superior aspect of the L1 vertebra)\\],\n2. Abnormalities of the aorta or iliac arteries that would prevent safe device placement, including aneurysms, significant tortuosity, or calcifications,\n3. Ilio-femoral diameter or peripheral vascular anatomy that would preclude safe placement of a 21F (outer diameter) introducer sheath including severe obstructive calcification or severe tortuosity,\n4. Known connective tissue disorder (e.g. Marfan Syndrome) or other aortopathy at risk of vascular injury;\n\n   20) Known hypersensitivity or contraindication to study or procedure medications (e.g.\n\n   anticoagulation therapy) or device materials (e.g. history of severe reaction to nickel or nitinol);\n\n   21) Positive pregnancy test if of childbearing potential;\n\n   22) Participation in any other clinical investigation that is likely to confound study results or affect the study;\n\n   23) Unable or unwilling to undergo screening (imaging, PA Catheter placement), device implant and retrieval procedures.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "21 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "University of Southern California", "city": "Los Angeles", "state": "California", "zip": "90033", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "University of California, San Francisco", "city": "San Francisco", "state": "California", "zip": "94143", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "University of Colorado", "city": "Denver", "state": "Colorado", "zip": "80045", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "University of Florida", "city": "Gainesville", "state": "Florida", "zip": "32610", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"facility": "University of South Florida", "city": "Tampa", "state": "Florida", "zip": "33620", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Cleveland Clinic Florida", "city": "Weston", "state": "Florida", "zip": "33331", "country": "United States", "geoPoint": {"lat": 26.10037, "lon": -80.39977}}, {"facility": "University of Chicago", "city": "Chicago", "state": "Illinois", "zip": "60637", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "University of Michigan", "city": "Ann Arbor", "state": "Michigan", "zip": "48109", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}, {"facility": "Henry Ford Health System", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Columbia University/New York Presbyterian", "city": "New York", "state": "New York", "zip": "10032", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "Christ Hospital", "city": "Cincinnati", "state": "Ohio", "zip": "45219", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "Houston Methodist", "city": "Houston", "state": "Texas", "zip": "77030", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "Inova Health Care Services", "city": "Falls Church", "state": "Virginia", "zip": "20042", "country": "United States", "geoPoint": {"lat": 38.88233, "lon": -77.17109}}, {"facility": "Sentara Hospital", "city": "Norfolk", "state": "Virginia", "zip": "23502", "country": "United States", "geoPoint": {"lat": 36.84681, "lon": -76.28522}}, {"facility": "St. Vincent's Hospital", "city": "Sydney", "state": "New South Wales", "country": "Australia", "geoPoint": {"lat": -33.86785, "lon": 151.20732}}, {"facility": "Prince Charles Hospital", "city": "Brisbane", "state": "Queensland", "country": "Australia", "geoPoint": {"lat": -27.46794, "lon": 153.02809}}, {"facility": "Royal Adelaide Hospital", "city": "Adelaide", "state": "South Australia", "country": "Australia", "geoPoint": {"lat": -34.92866, "lon": 138.59863}}, {"facility": "The Alfred Hospital", "city": "Melbourne", "state": "Victoria", "country": "Australia", "geoPoint": {"lat": -37.814, "lon": 144.96332}}, {"facility": "Western Health, Footscray Hospital", "city": "Melbourne", "state": "Victoria", "country": "Australia", "geoPoint": {"lat": -37.814, "lon": 144.96332}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "21"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "18"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "18"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "9"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "9"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "60.3", "spread": "7.9"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "8"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "10"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "15"}]}]}, {"title": "Black/African", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "17"}]}]}, {"title": "Australia", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}]}, {"title": "Baseline Ejection Fraction (%)", "paramType": "MEDIAN", "dispersionType": "INTER_QUARTILE_RANGE", "unitOfMeasure": "%", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "22.5", "lowerLimit": "10", "upperLimit": "53.5"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Serious Adverse Events", "description": "Rate of Occurrence of Serious Adverse Events (rate will be calculated and reported)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Events", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18"}]}]}]}, {"type": "PRIMARY", "title": "Serious Procedure Related Adverse Events", "description": "Rate of Occurrence of Serious Procedure Related Adverse Events (rate will be calculated and reported)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Events", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "7"}]}]}]}, {"type": "PRIMARY", "title": "Device Performance", "description": "Deployment and retrieval procedures success rates (rates will be calculated and reported).", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "percentage of subjects", "timeFrame": "7 days", "groups": [{"id": "OG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}]}], "classes": [{"title": "Implant Success Rate", "categories": [{"measurements": [{"groupId": "OG000", "value": "100"}]}]}, {"title": "Retrieval Success Rate", "categories": [{"measurements": [{"groupId": "OG000", "value": "100"}]}]}]}, {"type": "PRIMARY", "title": "Device Performance", "description": "Rate of occurrence of ADS, ARS and pump device-related adverse events (includes device malfunctions) (rate will be calculated and reported)", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "event", "timeFrame": "30 days", "groups": [{"id": "OG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "PRIMARY", "title": "Effectiveness", "description": "Clinically significant decongestion as measured by the PA catheter. % of patients with a decrease in either CVP or PCWP of \\> 20%.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "% of patients with specified decrease", "timeFrame": "7 days", "groups": [{"id": "OG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "89"}]}]}]}, {"type": "PRIMARY", "title": "Urine Output", "description": "Change in Urine Output Assessed as the hourly rate of urine output before pump placed vs hourly rate of urine output over the Aortix therapy period (until congestion target met or therapy deemed ineffective)", "populationDescription": "Patients Receiving Aortix Device", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Full Range", "unitOfMeasure": "mL/hr of Urine Output", "timeFrame": "7 day period starting from implant", "groups": [{"id": "OG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}]}], "classes": [{"title": "Baseline Hourly Urine Output", "categories": [{"measurements": [{"groupId": "OG000", "value": "113.7", "lowerLimit": "76.0", "upperLimit": "167.1"}]}]}, {"title": "Peak Urine Output During Treatment", "categories": [{"measurements": [{"groupId": "OG000", "value": "236", "lowerLimit": "177.4", "upperLimit": "293.8"}]}]}]}, {"type": "PRIMARY", "title": "NT-pro-BNP (Brain Natriuretic Peptide)", "description": "Change in NT-pro-BNP (pre-implant vs when congestion target is met or therapy deemed ineffective)", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Inter-Quartile Range", "unitOfMeasure": "pg/mL", "timeFrame": "7 days", "groups": [{"id": "OG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1,763", "lowerLimit": "-3,613", "upperLimit": "180"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "2 years; timeframe is from enrollment to 30-day visit.", "eventGroups": [{"id": "EG000", "title": "Aortix Device", "description": "Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System\n\nAortix System: Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) with worsening renal function.", "deathsNumAffected": 2, "deathsNumAtRisk": 21, "seriousNumAffected": 11, "seriousNumAtRisk": 21, "otherNumAffected": 11, "otherNumAtRisk": 21}], "seriousEvents": [{"term": "Arrest, Cardiac", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Bleeding/Femoral Access", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 21}]}, {"term": "Pulmonary Embolism", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Urinary Tract Infection", "organSystem": "Infections and infestations", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Thrombotic Vascular Complication", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 21}]}, {"term": "Bleeding, GI Bleed", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Vascular Injury (NonAorta)", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 21}]}, {"term": "Device Migration/Dislodgement", "organSystem": "Product Issues", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Hemolysis", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Hepatic Dysfunction", "organSystem": "Renal and urinary disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Hypotension", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Renal Injury, AKIN Stage 2", "organSystem": "Renal and urinary disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}, {"term": "Worsening Heart Failure", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 21}]}], "otherEvents": [{"term": "Bleeding Event", "organSystem": "Vascular disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 21}]}, {"term": "GI Miscellaneous", "organSystem": "Gastrointestinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 21}]}, {"term": "Hemolysis", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 21}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "Larger samples and a study powered to allow comparison with SOC is needed to confirm decongestion and renal benefits from IAEP and to identify a HF pt group that would benefit the most. An 18F sheath is required for device deployment, pts require systemic anticoagulation, and ICU monitoring was required. The implant procedure should be validated with various operators; the efficacy, performance, and safety of IAEP should be studied in a RCT; and consider extra costs of therapy vs pt outcomes."}, "certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Rubi Reyes-Fuentez, Clinical Research Associate II", "organization": "Procyrion, Inc.", "email": "rubi@procyrion.com"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2021-07-24", "uploadDate": "2023-10-19T19:48", "filename": "Prot_000.pdf", "size": 1145100}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2022-03-23", "uploadDate": "2024-02-14T10:18", "filename": "SAP_003.pdf", "size": 522962}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2023-11-18", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000059347", "term": "Cardio-Renal Syndrome"}, {"id": "D000006333", "term": "Heart Failure"}, {"id": "D000054143", "term": "Heart Failure, Systolic"}, {"id": "D000054144", "term": "Heart Failure, Diastolic"}, {"id": "D000013577", "term": "Syndrome"}], "ancestors": [{"id": "D000004194", "term": "Disease"}, {"id": "D000010335", "term": "Pathologic Processes"}, {"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000051437", "term": "Renal Insufficiency"}, {"id": "D000007674", "term": "Kidney Diseases"}, {"id": "D000014570", "term": "Urologic Diseases"}, {"id": "D000052776", "term": "Female Urogenital Diseases"}, {"id": "D000005261", "term": "Female Urogenital Diseases and Pregnancy Complications"}, {"id": "D000091642", "term": "Urogenital Diseases"}, {"id": "D000052801", "term": "Male Urogenital Diseases"}], "browseLeaves": [{"id": "M16355", "name": "Syndrome", "asFound": "Syndrome", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M27579", "name": "Heart Failure, Systolic", "asFound": "Heart Failure, Systolic", "relevance": "HIGH"}, {"id": "M27583", "name": "Systolic Murmurs", "relevance": "LOW"}, {"id": "M27580", "name": "Heart Failure, Diastolic", "asFound": "Heart Failure, Diastolic", "relevance": "HIGH"}, {"id": "M29439", "name": "Cardio-Renal Syndrome", "asFound": "Cardiorenal Syndrome", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M26718", "name": "Renal Insufficiency", "relevance": "LOW"}, {"id": "M10698", "name": "Kidney Diseases", "relevance": "LOW"}, {"id": "M17319", "name": "Urologic Diseases", "relevance": "LOW"}, {"id": "M2875", "name": "Urogenital Diseases", "relevance": "LOW"}, {"id": "M27093", "name": "Female Urogenital Diseases", "relevance": "LOW"}, {"id": "M14127", "name": "Pregnancy Complications", "relevance": "LOW"}, {"id": "M8399", "name": "Female Urogenital Diseases and Pregnancy Complications", "relevance": "LOW"}, {"id": "M27095", "name": "Male Urogenital Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BXS", "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"}]}}, "hasResults": true}